Exane Derivatives Spdr Ser Tr Spdr S&P Biotech E Transaction History

Exane Derivatives

  • $157 Million
  • Q2 2022

A detailed history of Exane Derivatives transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Exane Derivatives holds 6,963 shares of XBI stock, worth $640,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,963
Previous 963 623.05%
Holding current value
$640,456
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022
BUY
$62.81 - $96.09 $376,860 - $576,540
6,000 Added 623.05%
6,963 $0
Q3 2021

Oct 26, 2021
BUY
$118.69 - $138.49 $7,358 - $8,586
62 Added 6.88%
963 $0
Q4 2020

Jan 27, 2021
SELL
$110.36 - $151.14 $21,961 - $30,076
-199 Reduced 18.09%
901 $0
Q3 2020

Oct 06, 2020
BUY
$103.87 - $120.36 $114,257 - $132,396
1,100 New
1,100 $0

Others Institutions Holding XBI

# of Institutions
927
Shares Held
101M
Call Options Held
28.4M
Put Options Held
33.4M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email